⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Dimenhydrinate

دیمن‌هیدرینات

⚠ Unverified

🌬️ Respiratory SystemAntihistamine antiemetic

🤰 Pregnancy:Use with caution 🤱 Breastfeeding:Use with caution 🇮🇷 Registered in Iran ⛔ 1 contraindications 🇺🇸 OTC under FDA monograph M009 ATC R06AA11

Market / country: 🇺🇸 USA

Dramamine (US)

🧮 Dose calculator

Disease / regimen

Motion sickness · Regimen source: FDA Dimenhydrinate (OTC) · Directions

• First dose 30–60 min before travel. 2–6 y: ½ tablet every 6–8 h, max 1½ tablets/day. 6–12 y: ½–1 tablet every 6–8 h, max 3/day. ≥12 y: 1–2 tablets every 4–6 h, max 8/day. FDA Dimenhydrinate (OTC) · Directions

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ Under 2 years only if directed by a doctor. FDA Dimenhydrinate (OTC) · Do not use

Warnings

• Ask a doctor first: breathing problems (emphysema, chronic bronchitis), glaucoma, urinary difficulty from prostate, sedatives. FDA Dimenhydrinate (OTC) · Ask a doctor before use

Formulations

50 mg tablet (scored) — tablet 🇺🇸 USA FDA Dimenhydrinate (OTC) · Active ingredient

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Dimenhydrinate (OTC) · Drug Facts – Warnings
“If pregnant or breast-feeding, ask a health professional before use.”
🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Dimenhydrinate (OTC) · Drug Facts – Warnings
“If pregnant or breast-feeding, ask a health professional before use.”
👶 ChildrenNo data
The source for this drug has no section for this group.
👴 Older adultsNo data
The source for this drug has no section for this group.
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)❌ None
DailyMed (FDA label)FDA Dimenhydrinate (OTC)
MedlinePlus (NIH)Dimenhydrinate
WHO ATC/DDDR06AA11
Darooyab (Iran)Dimenhydrinate

🇮🇷 Registered in Iran Darooyab · G-789/Dimenhydrinate

Dosage forms with Iranian generic codes, per Darooyab.

00448 · DIMENHYDRINATE 50MG TAB · قرص دیمنهیدرینات ۵۰ میلی‌گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Dimenhydrinate (OTC) · Active ingredient FDA Dimenhydrinate (OTC) · Directions FDA Dimenhydrinate (OTC) · Do not use FDA Dimenhydrinate (OTC) · Ask a doctor before use FDA Dimenhydrinate (OTC) · Drug Facts – Warnings FDA Dimenhydrinate (OTC) · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-789/Dimenhydrinate
Clinical review⚠ Unverified